Tanaka T, Takei J, Sasaki H. Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma. J Neurooncol 2024 Aug 31. doi: 10.1007/s11060-024-04806.
PMID: 39214934